Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019898232> ?p ?o ?g. }
- W2019898232 endingPage "4044" @default.
- W2019898232 startingPage "4040" @default.
- W2019898232 abstract "The location of biologically relevant epitopes on recombinant human beta interferon in which Ser-17 replaces Cys-17 (rh[Ser17]IFN-beta) was evaluated by testing the immunoreactivity of antibodies against 159 sequential, overlapping octamer peptides. Three monoclonal antibodies (mAbs) that neutralize rh[Ser17]IFN-beta biologic activity, designated A1, A5, and A7, bound to peptides spanning only residues 39-48, whereas nonneutralizing mAb bound less specifically at multiple sites near the amino terminus. The immunoreactivity of peptides spanning residues 40-47 that contained a series of single amino acid substitutions suggested that residues 41-43 (Pro-Glu-Glu) and 46 (Gln) are important for the binding of neutralizing mAbs. The reactivity of mAbs to larger synthetic peptides containing rh[Ser17]IFN-beta sequences from residue 32 through residue 56 was evaluated. All mAbs except A7 reacted with synthetic peptides representing rh[Ser17]IFN-beta residues 32-47, 40-56, and 32-56, but only mAbs A1 and A5 bound to the core peptide composed of residues 40-47. Peptide 32-56 effectively blocked the binding of mAbs A1 and A5 to rh[Ser17]IFN-beta and markedly inhibited their neutralizing activity. Biologic activity of the peptides was undetectable. Rabbit antisera raised against peptides 32-47 and 40-56 recognized rh[Ser17]IFN-beta but did not neutralize its antiviral activity. Thus, structure-function analysis by peptide mapping has permitted the identification of a linear epitope recognized by neutralizing antibody on a biologically active cytokine. We conclude that the region spanning residues 32-56 is of major importance in the expression of the biologic activity of human IFN-beta." @default.
- W2019898232 created "2016-06-24" @default.
- W2019898232 creator A5005781064 @default.
- W2019898232 creator A5023763712 @default.
- W2019898232 creator A5032213013 @default.
- W2019898232 creator A5041795412 @default.
- W2019898232 date "1991-05-01" @default.
- W2019898232 modified "2023-10-11" @default.
- W2019898232 title "Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping." @default.
- W2019898232 cites W1505277495 @default.
- W2019898232 cites W1511116368 @default.
- W2019898232 cites W1523048906 @default.
- W2019898232 cites W1545632338 @default.
- W2019898232 cites W1548276373 @default.
- W2019898232 cites W1549389405 @default.
- W2019898232 cites W1555507143 @default.
- W2019898232 cites W1558098254 @default.
- W2019898232 cites W1565589271 @default.
- W2019898232 cites W1579405605 @default.
- W2019898232 cites W1660042909 @default.
- W2019898232 cites W1841905389 @default.
- W2019898232 cites W1976232165 @default.
- W2019898232 cites W1997868973 @default.
- W2019898232 cites W2004287566 @default.
- W2019898232 cites W2016627629 @default.
- W2019898232 cites W2023020161 @default.
- W2019898232 cites W2025005784 @default.
- W2019898232 cites W2031332665 @default.
- W2019898232 cites W2035893045 @default.
- W2019898232 cites W2046434858 @default.
- W2019898232 cites W2053170408 @default.
- W2019898232 cites W2053591132 @default.
- W2019898232 cites W2054076849 @default.
- W2019898232 cites W2055708140 @default.
- W2019898232 cites W2065335184 @default.
- W2019898232 cites W2073455402 @default.
- W2019898232 cites W2081217040 @default.
- W2019898232 cites W2083135286 @default.
- W2019898232 cites W2086433960 @default.
- W2019898232 cites W2118906352 @default.
- W2019898232 cites W2136398262 @default.
- W2019898232 cites W2136701955 @default.
- W2019898232 cites W2149464124 @default.
- W2019898232 cites W2155168348 @default.
- W2019898232 cites W2156907206 @default.
- W2019898232 cites W2160184108 @default.
- W2019898232 cites W2404860104 @default.
- W2019898232 cites W2416089418 @default.
- W2019898232 cites W2417295117 @default.
- W2019898232 doi "https://doi.org/10.1073/pnas.88.9.4040" @default.
- W2019898232 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/51589" @default.
- W2019898232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1708891" @default.
- W2019898232 hasPublicationYear "1991" @default.
- W2019898232 type Work @default.
- W2019898232 sameAs 2019898232 @default.
- W2019898232 citedByCount "35" @default.
- W2019898232 countsByYear W20198982322015 @default.
- W2019898232 crossrefType "journal-article" @default.
- W2019898232 hasAuthorship W2019898232A5005781064 @default.
- W2019898232 hasAuthorship W2019898232A5023763712 @default.
- W2019898232 hasAuthorship W2019898232A5032213013 @default.
- W2019898232 hasAuthorship W2019898232A5041795412 @default.
- W2019898232 hasBestOaLocation W20198982322 @default.
- W2019898232 hasConcept C104317684 @default.
- W2019898232 hasConcept C116073593 @default.
- W2019898232 hasConcept C153911025 @default.
- W2019898232 hasConcept C159654299 @default.
- W2019898232 hasConcept C167625842 @default.
- W2019898232 hasConcept C185592680 @default.
- W2019898232 hasConcept C195616568 @default.
- W2019898232 hasConcept C202751555 @default.
- W2019898232 hasConcept C203014093 @default.
- W2019898232 hasConcept C2779281246 @default.
- W2019898232 hasConcept C2781241564 @default.
- W2019898232 hasConcept C40767141 @default.
- W2019898232 hasConcept C515207424 @default.
- W2019898232 hasConcept C542903549 @default.
- W2019898232 hasConcept C55493867 @default.
- W2019898232 hasConcept C78598654 @default.
- W2019898232 hasConcept C86803240 @default.
- W2019898232 hasConcept C91523082 @default.
- W2019898232 hasConceptScore W2019898232C104317684 @default.
- W2019898232 hasConceptScore W2019898232C116073593 @default.
- W2019898232 hasConceptScore W2019898232C153911025 @default.
- W2019898232 hasConceptScore W2019898232C159654299 @default.
- W2019898232 hasConceptScore W2019898232C167625842 @default.
- W2019898232 hasConceptScore W2019898232C185592680 @default.
- W2019898232 hasConceptScore W2019898232C195616568 @default.
- W2019898232 hasConceptScore W2019898232C202751555 @default.
- W2019898232 hasConceptScore W2019898232C203014093 @default.
- W2019898232 hasConceptScore W2019898232C2779281246 @default.
- W2019898232 hasConceptScore W2019898232C2781241564 @default.
- W2019898232 hasConceptScore W2019898232C40767141 @default.
- W2019898232 hasConceptScore W2019898232C515207424 @default.
- W2019898232 hasConceptScore W2019898232C542903549 @default.
- W2019898232 hasConceptScore W2019898232C55493867 @default.
- W2019898232 hasConceptScore W2019898232C78598654 @default.
- W2019898232 hasConceptScore W2019898232C86803240 @default.